Search

Your search keyword '"Wu, Chin-Lee"' showing total 1,118 results

Search Constraints

Start Over You searched for: Author "Wu, Chin-Lee" Remove constraint Author: "Wu, Chin-Lee"
1,118 results on '"Wu, Chin-Lee"'

Search Results

501. Accumulation of E2F-4·DP-1 DNA Binding Complexes Correlates with Induction of dhfrGene Expression during the G1to S Phase Transition*

502. Metabolomic prostate cancer fields in HRMAS MRS‐profiled histologically benign tissue vary with cancer status and distance from cancer.

503. Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

504. Sex differences in oncogenic mutational processes

505. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

507. Sex differences in oncogenic mutational processes

508. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

510. Pan-cancer analysis of whole genomes

511. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

512. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

513. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

514. Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.

516. To stage or not to stage: determining the true clinical significance of the biopsy tract through perinephric fat in assessing renal cell carcinoma.

518. CD13 Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma.

520. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.

521. Estimated Prostate Volume by Semiautomatic Segmentation of MRI Is More Accurately Correlated with Radical Prostatectomy Specimen Weight than the Volume Calculated by Ellipsoid Formula.

523. MP50-09 ROLE OF REPEAT BIOPSY IN THE FOLLOW-UP OF RENAL LESIONS WITH A PRIOR NON-DIAGNOSTIC BIOPSY OF THE SAME MASS.

525. MP50-08 DIAGNOSTIC SUCCESS AND PREDICTION OF TUMOR SUBTYPE OF RENAL MASS BIOPSY IMPROVES WITH EXPERIENCE: LONGITUDINAL RESULTS IN A SINGLE SERIES COHORT OF 1233 TUMORS.

526. CD13hiNeutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma

527. TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.

528. Detection of extraprostatic extension by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted combined with systemic template prostate biopsy.

529. Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.

530. Ex Vivo High-Resolution Magic Angle Spinning (HRMAS) 1 H NMR Spectroscopy for Early Prostate Cancer Detection.

531. A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.

532. Novel CFD modeling approaches to assessing urine flow in prostatic urethra after transurethral surgery.

533. Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy.

534. Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma.

535. Resolution of a High Grade and Metastatic BK Polyomavirus-Associated Urothelial Cell Carcinoma Following Radical Allograft Nephroureterectomy and Immune Checkpoint Treatment: A Case Report.

536. Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis.

537. Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.

538. The clinicopathological characteristics and prognostic value of squamous differentiation in patients with bladder urothelial carcinoma: a meta-analysis.

539. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis.

540. Prognostic significance of laterality in renal cell carcinoma: A population‐based study from the surveillance, epidemiology, and end results (SEER) database.

541. Prognostic value of a gene signature in clear cell renal cell carcinoma.

542. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.

543. Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.

544. MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment.

545. Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imaging.

546. Case 36-2018: A 29-Year-Old Man with an Incidentally Discovered Renal Mass.

547. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.

548. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.

549. Characterization of the metabolomic profile of renal cell carcinoma by high resolution magic angle spinning proton magnetic resonance spectroscopy.

550. Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.

Catalog

Books, media, physical & digital resources